7-33905659-C-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001365308.1(BMPER):c.46C>A(p.Arg16Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R16L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001365308.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BMPER | NM_001365308.1 | c.46C>A | p.Arg16Ser | missense_variant | 1/15 | ENST00000649409.2 | |
BMPER | NM_133468.5 | c.46C>A | p.Arg16Ser | missense_variant | 2/16 | ||
BMPER | NM_001410872.1 | c.46C>A | p.Arg16Ser | missense_variant | 1/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BMPER | ENST00000649409.2 | c.46C>A | p.Arg16Ser | missense_variant | 1/15 | NM_001365308.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151996Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000720 AC: 18AN: 250164Hom.: 0 AF XY: 0.0000885 AC XY: 12AN XY: 135532
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461328Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727002
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151996Hom.: 0 Cov.: 29 AF XY: 0.0000269 AC XY: 2AN XY: 74234
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2023 | The c.46C>A (p.R16S) alteration is located in exon 1 (coding exon 1) of the BMPER gene. This alteration results from a C to A substitution at nucleotide position 46, causing the arginine (R) at amino acid position 16 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 08, 2022 | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 16 of the BMPER protein (p.Arg16Ser). This variant is present in population databases (rs760953708, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with BMPER-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at